Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC.
Astrid E Persson, Elisabeth Kjellén, Hans Garmo, Gabriel Adrian, Pär Stattin, Anders Widmark, Per Nilsson, Adalsteinn Gunnlaugsson
Published: 202510.1016/j.radonc.2025.111323
Abstract
BACKGROUND AND PURPOSE: HYPO-RT-PC was the first phase 3 trial showing the long-term efficacy and safety of extremely hypofractionated radiotherapy schedules (ultra-hypofractionation or stereotactic body radiotherapy) compared with standard radiother…
Preview only. Read the full abstract at the source